← Back to Search

Behavioural Intervention

SmokefreeTXT + smartband for Smoking Cessation

N/A

Recruiting

Led By Kathleen A Garrison, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4 weeks and 8 weeks

Awards & highlights

Study Summary

This trial aims to study the effectiveness of a quit smoking text messaging program with or without a smartband on a large group of people.

Who is the study for?

This trial is for daily smokers who have been smoking for at least six months and are interested in quitting. It's not open to individuals already enrolled in another quit smoking program.Check my eligibility

What is being tested?

The study is testing the effectiveness of a quit smoking text messaging service called SmokefreeTXT, with some participants also using a smartband. Participants will be randomly placed into groups to receive either just the texts or texts plus the smartband.See study design

What are the potential side effects?

Since this trial involves non-medical interventions (text messages and a smartband), there are no direct medical side effects associated with them. However, participants may experience stress or anxiety related to quitting smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4 weeks and 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4 weeks and 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with cotinine confirmed 7-day point-prevalence abstinence (PPA) at end of treatment (8 weeks)

Secondary outcome measures

Average number of days to relapse

Change in cigarettes smoked per day

Percent days smoke-free

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SmokefreeTXT + smartbandExperimental Treatment2 Interventions

Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT + smartband.

Group II: SmokefreeTXTActive Control1 Intervention

Daily smokers for at least 6 months who report an interest in quitting will be randomized to receive the National Cancer Institute's SmokefreeTXT.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

American Lung AssociationOTHER

31 Previous Clinical Trials

10,773 Total Patients Enrolled

Yale UniversityLead Sponsor

1,853 Previous Clinical Trials

2,738,361 Total Patients Enrolled

Kathleen A Garrison, PhDPrincipal InvestigatorYale University

2 Previous Clinical Trials

666 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing enrollment process for participants in this medical study?

"The ongoing recruitment of subjects for this investigation is documented on clinicaltrials.gov. The trial was initially publicized on March 26, 2024, and last revised on March 27, 2024."

Answered by AI

What is the current number of subjects participating in this investigation?

"Yes, the details on clinicaltrials.gov indicate that this investigation is currently seeking individuals to participate. The trial was first listed on March 26th, 2024, and its most recent update occurred on March 27th, 2024. This research project aims to enlist a total of 200 participants from one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quit Smoking Text Message Study

2024. "Quit Smoking Text Message Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06111755.